Susan G. Komen® has awarded Melissa Troester, PhD, MPH, a two-year, $200,000 leadership grant to support her investigations of the clinical impact of spatial heterogeneity in a tumor.
UNC Lineberger Director Shelley Earp, MD, has been appointed chair of the NCI Board of Scientific Advisors. The board advises the NCI director and program leaders on research priorities.
UNC and UNC Lineberger researchers and trainees will be presenting talks and participating in scientific and educational panels and discussions on the latest cancer research at the ASCO Annual Meeting.
Lisa Carey, MD, ScM, FASCO, was honored for her distinguished service over the years leading outstanding clinical and translational research and her work in eradicating health disparities.
Researchers and trainees from UNC and UNC Lineberger at will present more than 30 talks and participate in scientific and educational panels and discussions on the latest cancer research.
A team of UNC researchers investigated how cell cycle flexibility allows tumor cells to escape the effect of anti-cancer drugs that target cell division.
Missy Van Lokeren was diagnosed with metastatic breast cancer in 2018, and has became a patient advocate spreading awareness for tissue donation through the Patients And Researchers Together (PART) program.
New findings from Gaorav Gupta, MD, PhD, and colleagues show how the cGAS-STING pathway is unleashed to prevent cancer formation by detecting DNA damage within cells.
Yara Abdou, MD, Dominique Higgins, MD, PhD, and Joannie Ivory, MD, recently received career development awards from the Robert A. Winn Diversity in Clinical Trials Program.
The San Antonio Breast Cancer Symposium features presentations outlining basic, translational, clinical and community-based study findings focused on advancing the prevention, diagnosis and treatment of breast cancer.
Sarah Chaires, FNP, never thought that she would slip off the white medical provider lab coat and slip into a patient hospital gown. But everything redirected for the Chaires family when she was diagnosed with HER2-positive breast cancer.
A group of UNC Lineberger researchers led by Katie Reeder-Hayes, MD, MSc, MBA, will develop new methods to measure and map cancer screening across North Carolina.